Avidity Partners Management LP lessened its stake in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) by 96.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 64,501 shares of the company’s stock after selling 1,692,439 shares during the quarter. Avidity Partners Management […]
Amylyx Pharmaceuticals, Inc (NASDAQ:AMLX) Receives Average Recommendation of Hold from Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 5,090,000 shares, a growth of 16.5% from the February 29th total of 4,370,000 shares. Based on an average daily trading volume, of 2,790,000 shares, the days-to-cover […]
Amylyx Pharmaceuticals (AMLX) In-Line Rating Reiterated at Evercore ISI themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Primecap Management Co. CA purchased a new stake in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 304,900 shares of the company’s stock, valued at approximately $5,583,000. Primecap Management Co. CA owned […]